about
Cellular mediators of renal vascular dysfunction in hypertensionEndothelinFunctional O-GlcNAc modifications: implications in molecular regulation and pathophysiologyBlood-Brain Barrier Disruption Induced by Chronic Sleep Loss: Low-Grade Inflammation May Be the LinkAmbrisentan, a non-peptide endothelin receptor antagonistVascular endothelin receptor type B: structure, function and dysregulation in vascular diseaseO-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathwayMurine and rat cavernosal responses to endothelin-1 and urotensin-II Vasoactive Peptide SymposiumADP-ribosyl cyclase and ryanodine receptors mediate endothelin ETA and ETB receptor-induced renal vasoconstriction in vivoUp-regulation of endothelin type B receptors in the human internal mammary artery in culture is dependent on protein kinase C and mitogen-activated kinase signaling pathwaysIncreased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease.O-GlcNAcylation contributes to augmented vascular reactivity induced by endothelin 1.TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults.Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patientsImpairment in function and expression of transient receptor potential vanilloid type 4 in Dahl salt-sensitive rats: significance and mechanismDownregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancyAntenatal betamethasone increases vascular reactivity to endothelin-1 by upregulation of CD38/cADPR signaling.ENDOTHELIN-1 SYTEM ACTIVITY IN ADULTS WITH BORDERLINE HIGH LDL-CHOLESTEROL.O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension.O-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.Mechanisms of arterial remodeling in hypertension: coupled roles of wall shear and intramural stress.Modulators of the vascular endothelin receptor in blood pressure regulation and hypertension.Enhanced endothelin-1 system activity with overweight and obesityIntracellular endothelin type B receptor-driven Ca2+ signal elicits nitric oxide production in endothelial cells.Abnormal heart development and lung remodeling in mice lacking the hypoxia-inducible factor-related basic helix-loop-helix PAS protein NEPASEndothelin-1 and the kidney--beyond BP.Vasoactive peptides in cardiovascular (patho)physiology.State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension.Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?Hypertension, cardiac hypertrophy, and impaired vascular relaxation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are associated with increased superoxide.Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin?Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.DOCA-salt treatment enhances responses to endothelin-1 in murine corpus cavernosum.Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis.Endothelin 1 activation of endothelin A receptor/NADPH oxidase pathway and diminished antioxidants critically contribute to endothelial progenitor cell reduction and dysfunction in salt-sensitive hypertension.Circulatory therapeutics: use of antihypertensive agents and their effects on the vasculature.Role of ambrisentan in the management of pulmonary hypertension.Enhanced endothelin receptor type B-mediated vasodilation and underlying [Ca²⁺]i in mesenteric microvessels of pregnant rats.Endothelin Type A Receptor Genotype is a Determinant of Quantitative Traits of Metabolic Syndrome in Asian Hypertensive Families: A SAPPHIRe Study.
P2860
Q24644250-7CB73339-4CD3-42A1-8BAE-BA1D9D4F8035Q26767156-84F0EB7D-2ED6-431C-AAA4-797AD13A9C82Q27009399-2D2FD8B8-44D6-4233-B226-AE0C6C7FC282Q28076258-A8C43786-6082-422C-A234-7FE7368ED139Q28260732-A59BE16C-F8A9-4087-AEE6-3606C789F02FQ28263963-504A7F10-9EEF-4A76-A590-86E2ACFB4325Q28571140-5ACA05CC-91B8-4700-A3CB-A5E5BBF240B2Q28574132-E80C0896-2152-4D8D-9C1C-7E13C9C06D62Q28581548-724134F1-CC12-482A-9DB5-1AF170F0ECC3Q33367779-DE323558-065C-4EBD-A29E-594BF9538E80Q33496583-10BFDDA1-D762-4CF0-84B3-B42754347167Q33599905-A6B4E966-FC2B-41E3-8ABE-E914C27E59BBQ33647618-8F0EB967-F808-47D2-BE57-E59830A1F3E5Q33686561-3AC4B006-096A-402B-A81A-DA795308E60EQ33765684-9FBE4E9C-8A42-4468-AB14-633EDE87C602Q33822709-ED41EABC-2505-411A-A367-14AB26EBC37DQ34051646-2F91D771-4F95-4EBB-B045-B2372A94052AQ34159706-964692A3-BA3E-4841-AB2D-AA4033AA304FQ34245580-D21FB245-3973-4468-BD02-E4971F4EAE92Q34498193-9648D0D3-CE40-4801-9601-606FA7DD1E60Q34598611-E66ED733-797C-4479-80CF-9758C243C211Q34785619-EEB9EBDE-BD8F-482A-9115-B977FAED3379Q35100291-B0291A5E-89AA-473D-BEF6-D471F6585D3CQ35314860-6BE08F90-1007-4D16-A022-F87841E4C052Q36436029-0A7587B7-3AA1-4A9A-B5A8-13CA86AC6D07Q36483402-6E11909A-2B8E-48D6-BF3B-636DA91B4A75Q36619734-EA618C14-4A90-4049-8B10-0E4BB606809CQ36815987-35A86AAD-E5EE-4F72-8142-10A8D363ED54Q37078824-870CBE4B-5F3A-4668-AFEA-E7DD66482AFFQ37082781-393A4B1F-84C7-4FE5-AF82-D52A83C91BBCQ37111663-93F9565A-5D3E-4E6D-A165-127692F5E537Q37131819-380FAA2A-E9F1-43EC-9B8F-22EBDC6B2AB1Q37149082-78A1A7F9-F5D0-4B0D-9477-713D6A63A182Q37195765-17F920F0-ABC8-4F23-8DF4-7F2157B5F24EQ37203406-21F4052E-1B9C-442D-9290-891C373DFD8FQ37225174-AA14EB14-B867-46E7-940E-BFD0FB36343AQ37294341-B9C96B1D-E9B4-474F-BFEC-543F4B70FB44Q37310683-C674FCBA-9BBA-46C5-87C0-7071955CC7C8Q37318884-C595F6E9-32FC-402A-AFA1-14109BA338FEQ37347744-E495DD66-81A6-4344-9D09-DCD9C02FE183
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Vascular endothelin in hypertension.
@ast
Vascular endothelin in hypertension.
@en
type
label
Vascular endothelin in hypertension.
@ast
Vascular endothelin in hypertension.
@en
prefLabel
Vascular endothelin in hypertension.
@ast
Vascular endothelin in hypertension.
@en
P1476
Vascular endothelin in hypertension.
@en
P2093
Ernesto L Schiffrin
P356
10.1016/J.VPH.2005.03.004
P577
2005-06-01T00:00:00Z